Basis of allocation of ₹920 crore Park Medi World IPO The announcement will be made today, December 15, 2025. The bidding window was open from December 10, 2025 to December 12, 2025, during which the IPO received a total subscription of 8.10x.
Process to check Park Medi World IPO allotment status online on NSE
- Visit NSE’s IPO allotment verification status page Here,
- choose “Equity and SME IPO Bid Details”.
- select in select symbol “ParkHospitals”.
- Enter your PAN number and application number.
- Click on “Submit”.
Process to check Park Medi World IPO allotment status online on BSE
- Click Here To go to the application status page.
- In digit type, “equity”.
- In the issue name, select “PARK MEDI WORLD LTD”.
- enter your “No application.” Or “PAN Number.”
- click on “I’m no robot”.
- Click on “Submit”.
Process to check Park Medi World IPO allotment status on Kfin Technologies Limited (Registrar to the Issue):
- Visit Kfin Technologies IPO Allotment Status page Here,
- Click on any link.
- Select in Select IPO ,Park Medi World Limited”.
- Enter any of the following details.
- pan
- Application. No.
- demat account
- Enter captcha and click “submit”.
Park Medi World IPO Details
Park Medi World IPO is a book-building issue of ₹920 crore, comprising a fresh issue of ₹770 crore and an offer for sale (OFS) of ₹150 crore. The price band has been set between ₹154 and ₹162 per share.
The book-running lead managers for the IPO are Nuvama Wealth Management Ltd, CLSA India Pvt Ltd, DAM Capital Advisors Ltd and Intensive Fiscal Services Pvt Ltd. Whereas, Kfin Technologies Limited is the registrar of the issue.
use of proceeds
The net proceeds from the fresh issue will be used for the following purposes:
- general corporate objectives
- capital expenditure fund for
- Development of a new hospital by subsidiary company, Park Medicity (NCR)
- Procurement of medical equipment by the Company and its subsidiaries, Blue Heavens and Ratangiri
- Repayment/prepayment of outstanding borrowings taken by the company and its subsidiaries
- undisclosed inorganic acquisition
Park Medi World IPO GMP
according to media reportsThe gray market premium (GMP) of Park Medi World is said to be ₹6.5 higher than the IPO price.
Park Medi World IPO Overall Subscription Status
[12-December-2025 19:00:00 hrs]
|
investor category |
membership (time) |
|
Qualified Institutional Buyer (QIB) |
11.48 |
|
non-institutional investors |
15.15 |
|
Retail Individual Investors (RII) |
3.16 |
|
Total |
8.10 |
Park Medi World Business Overview
Park Medi World is one of North India’s leading private healthcare providers, operating a growing network of advanced multi-super specialty hospitals. Their portfolio includes 14 NABH-accredited hospitals, eight of which also have NABL certification, with a total capacity of approximately 3,000 beds across the region.
Disclaimer: This news is purely for educational purposes. The securities/investments quoted here are not recommendations.
Please click to read RA Disclaimer Here,